636. A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Live, Attenuated, Quadrivalent Dengue Vaccine (V181)

por Russell, Kevin, Rupp, Richard E, Morales-Ramirez, Javier O, Diaz-Perez, Clemente, Andrews, Charles P, Lee, Andrew W, Finn, Tyler S, Cox, Kara, Russell, Amy Falk, Schaller, Margaret M, Martin, Jason C, Hyatt, Donna M, Gozlan-Kelner, Sabrina, Bili, Androniki, Coller, Beth-Ann
Publicado 2021

A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus...

por Russell, Kevin L., Rupp, Richard E., Morales-Ramirez, Javier O., Diaz-Perez, Clemente, Andrews, Charles P., Lee, Andrew W., Finn, Tyler S., Cox, Kara S., Falk Russell, Amy, Schaller, Margaret M., Martin, Jason C., Hyatt, Donna M., Gozlan-Kelner, Sabrina, Bili, Androniki, Coller, Beth-Ann G.
Publicado 2022

Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine – A combined analysis of five phase III clinical trials

por Petersen, Lone K., Restrepo, Jaime, Moreira, Edson D., Iversen, Ole-Erik, Pitisuttithum, Punnee, Van Damme, Pierre, Joura, Elmar A., Olsson, Sven-Erik, Ferris, Daron, Block, Stan, Giuliano, Anna R., Bosch, Xavier, Pils, Sophie, Cuzick, Jack, Garland, Suzanne M., Huh, Warner, Kjaer, Susanne K., Bautista, Oliver M., Hyatt, Donna, Maansson, Roger, Moeller, Erin, Qi, Hong, Roberts, Christine, Luxembourg, Alain
Publicado 2017